7-(7-fluoro-2-methylindazol-5-yl)-2-(2,2,6,6-tetramethylpiperidin-4-yl)-[1,3]thiazolo[3,2-a]pyrimidin-5-one
C23H26FN5OS — CID 156888571
Data last refreshed: (MolForge compound catalog, from PubChem)
About 7-(7-fluoro-2-methylindazol-5-yl)-2-(2,2,6,6-tetramethylpiperidin-4-yl)-[1,3]thiazolo[3,2-a]pyrimidin-5-one
7-(7-fluoro-2-methylindazol-5-yl)-2-(2,2,6,6-tetramethylpiperidin-4-yl)-[1,3]thiazolo[3,2-a]pyrimidin-5-one (PubChem CID 156888571) has the molecular formula C23H26FN5OS and a molecular weight of 439.56 g/mol. Its IUPAC name is 7-(7-fluoro-2-methylindazol-5-yl)-2-(2,2,6,6-tetramethylpiperidin-4-yl)-[1,3]thiazolo[3,2-a]pyrimidin-5-one.
Molecular Properties
| Compound Name | 7-(7-fluoro-2-methylindazol-5-yl)-2-(2,2,6,6-tetramethylpiperidin-4-yl)-[1,3]thiazolo[3,2-a]pyrimidin-5-one |
|---|---|
| PubChem CID | 156888571 |
| Molecular Formula | C23H26FN5OS |
| Molecular Weight | 439.56 g/mol |
| Exact Mass | 439.18 |
| IUPAC Name | 7-(7-fluoro-2-methylindazol-5-yl)-2-(2,2,6,6-tetramethylpiperidin-4-yl)-[1,3]thiazolo[3,2-a]pyrimidin-5-one |
| SMILES | Cn1cc2cc(-c3cc(=O)n4cc(C5CC(C)(C)NC(C)(C)C5)sc4n3)cc(F)c2n1 |
| InChI | InChI=1S/C23H26FN5OS/c1-22(2)9-15(10-23(3,4)27-22)18-12-29-19(30)8-17(25-21(29)31-18)13-6-14-11-28(5)26-20(14)16(24)7-13/h6-8,11-12,15,27H,9-10H2,1-5H3 |
| InChIKey | ULSNXRNCTUCMRL-UHFFFAOYSA-N |
| XLogP | 4.47 |
| TPSA | 64.22 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 439.56 |
| LogP ≤ 5 | 4.47 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156888571 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.